Maximum quantity allowed is 999
CAS RN: 98753-19-6 | Product Number: C3007
Cefpirome Sulfate

Purity: >95.0%(HPLC)(N)
Size | Unit Price | Same Day | 2-3 Business Days | Other Lead Time |
Shipping Information
![]() |
---|---|---|---|---|---|
1G |
NT$2,352
|
1 | 0 | Contact Us | |
5G |
NT$8,106
|
9 | 0 | Contact Us |
* The above prices include freight cost, customs, and other charges to the destination except for products that need to be shipped by sea or dry ice. For details, please contact
our distributor
in Taiwan to order our product.
* The storage conditions are subject to change without notice.
Supplemental Product Information:
This product has not been tested for potency and is guaranteed for chemical purity.
Product Number | C3007 |
Purity / Analysis Method ![]() |
>95.0%(HPLC)(N) |
Molecular Formula / Molecular Weight | C__2__2H__2__2N__6O__5S__2·H__2SO__4 = 612.65 |
Physical State (20 deg.C) | Solid |
Storage Temperature ![]() |
Refrigerated (0-10°C) |
Store Under Inert Gas | Store under inert gas |
Condition to Avoid | Hygroscopic,Heat Sensitive |
Packaging and Container ![]() |
1G-Glass Bottle with Plastic Insert (View image) |
CAS RN | 98753-19-6 |
Related CAS RN ![]() |
84957-29-9 |
Reaxys Registry Number | 11738005 |
PubChem Substance ID | 253661002 |
Merck Index (14) | 1940 |
MDL Number | MFCD11864966 |
Appearance | White to Almost white powder to crystal |
Purity(HPLC) | min. 95.0 area% |
Purity(with Total Nitrogen) | min. 95.0 % |
Specific rotation [a]20/D | -27.0 to -33.0 deg(C=2.5,a solution prepared by addition of water to 25mL of actonitrile to make 50mL)(calcd.on anh.substance) |
Water | max. 5.0 % |
Melting Point | 200 °C |
Specific Rotation | -30° (C=2.5,JP Method) |
Maximum Absorption Wavelength | 265 nm (Buffer) |
Solubility in water | Soluble |
Solubility (insoluble in) | Ether, Ethanol |
RTECS# | UW8970000 |
H.S.code* | 2941.90-000 |
References
- Stability and degradation pattern of cefpirome (HR 810) in aqueous solution
- Comparative study of pharmacokinetics and serum bactericidal activities of cefpirome, ceftazidime, ceftriaxone, imipenem, and ciprofloxacin
- Cefpirome: a review of its antibacterial activity, pharmacokinetic properties and clinical efficacy in the treatment of severe nosocomial infections and febrile neutropenia
- Development of an analytical method for cefpirome in plasma by simplified HPLC technique and its applications
- Stability-Indicating HPLC and RP-TLC Determination of Cefpirome Sulfate with Kinetic Study
Documents
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.